Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
85.4M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
52.4M
-
Shares change
-
-455K
-
Total reported value, excl. options
-
$378M
-
Value change
-
-$6.73M
-
Put/Call ratio
-
1.05
-
Number of buys
-
54
-
Number of sells
-
-67
-
Price
-
$7.22
Significant Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q1 2022
165 filings reported holding AVIR - Atea Pharmaceuticals, Inc. - COMMON STOCK as of Q1 2022.
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.4M shares
of 85.4M outstanding shares and own 61.43% of the company stock.
Largest 10 shareholders include FMR LLC (12.6M shares), VANGUARD GROUP INC (6.73M shares), BlackRock Inc. (6.62M shares), EcoR1 Capital, LLC (6.34M shares), Bain Capital Life Sciences Investors, LLC (2.49M shares), STATE STREET CORP (1.87M shares), CITADEL ADVISORS LLC (1.55M shares), Cormorant Asset Management, LP (1.55M shares), RENAISSANCE TECHNOLOGIES LLC (1.17M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.03M shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.